Human herpesvirus 8: An update

Microbes and Infection

Volumn 6, Issue 3, 2004, Pages 328-335

  De Paoli, Paolo ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

Diseases; Epidemiology; Human herpesvirus 8; Laboratory diagnosis

Indexed keywords

ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; PROTEINASE INHIBITOR; VIRUS ANTIGEN;

ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; CARCINOGENESIS; CARCINOGENIC ACTIVITY; DISEASE ASSOCIATION; DRUG SENSITIVITY; EPSTEIN BARR VIRUS; FEVER; GEOGRAPHIC DISTRIBUTION; GEOGRAPHICAL VARIATION (SPECIES); HERPES; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN HERPESVIRUS 8; IN VITRO STUDY; IN VIVO STUDY; INFECTION RISK; LABORATORY DIAGNOSIS; LEUKOPENIA; LYMPHADENOPATHY; ORGAN TRANSPLANTATION; POPULATION RISK; PRIMARY INFECTION; PRIORITY JOURNAL; PROTEINASE INHIBITION; REVIEW; RISK ASSESSMENT; SEROPREVALENCE; SPLENOMEGALY; VIRUS DETECTION; VIRUS INFECTION; VIRUS INFECTIVITY; VIRUS PATHOGENESIS; VIRUS TRANSMISSION;

HERPESVIRIDAE; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 8;

EID: 1542328235     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micinf.2003.11.013     Document Type: Short Survey

References (64)

1. Chang Y., Cesarman E., Pessin M.S., Lee F., Culpepper J., Knowles D.M., Moore P. Identification of herpesvirus-like sequences in AIDS-associated Kaposi's sarcoma. Science. 266:1994;1865-1869.
2. Schulz T.F. Epidemiology of Kaposi's sarcoma associated herpesvirus/ human herpesvirus 8. Adv. Cancer Res. 76:1999;121-160.
3. Neipel F., Albrecht J., Fleckenstein B. HHV-8 - the first human Rhadinovirus. J. Natl. Cancer Inst. Monogr. 23:1998;73-77.
4. Schulz T.F. Kaposi's sarcoma associated herpesvirus: epidemiology and pathogenesis. J. Antimicrob. Chemother. 45:2000;15-27. (Topic T3).
5. Hengge U.R., Ruzicka T., Tyring S., Struschke M., Roggendorf M., Schwartz R., Seeber S. Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 1: epidemiology, environmental predispositions, clinical manifestations and therapy. Lancet Infect. Dis. 2:2002;281-292.
6. Cannon M.J., Laney A.S., Pellett P. Human herpesvirus 8: current issues. Clin. Infect. Dis. 37:2003;82-87.
7. Dukers N.T., Rezza G. Human herpesvirus 8 epidemiology: what we do and what we do not know. AIDS. 17:2003;1717-1730.
8. Corey L., Brodie S., Huang M., Koelle D., Wald A. HHV-8 infection: a model for reactivation and transmission. Rev. Med. Virol. 12:2002;47-63.
9. Nicholas J., Zong J., Alcendor D., Ciufo D., Poole L., Sariky R., Chiou C., Zhang X., Wang X., Guo H., Reitz M., Hayward G. Novel organization features, captured cellular genes, and strain variability within the genome of KSV/HHV8. J. Natl. Cancer Inst. Monogr. 23:1998;79-88.
10. Gaidano G., Carbone A. Primary effusion lymphoma: a liquid phase lymphoma of fluid-filled body cavities. Adv. Cancer Res. 80:2001;115-146.
11. Dourmishev L., Dourmishev A.L., Palmeri D., Schwartz R., Lukac D. Molecular genetics of Kaposi's sarcoma associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis. Microbiol. Mol. Biol. Rev. 67:2003;175-212.
12. McGeoch J.D., Davidson A. The descent of human herpesvirus-8. Semin. Cancer Biol. 9:1999;201-209.
13. Lin S., Sun R., Heston L., Gradonville L., Shedd D., Haglund K., Risby M., Miller G. Identification, expression and immunogenicity of KSHV encoded small viral capsid antigen. J. Virol. 71:1997;3069-3076.
14. Zong J., Ciufo D., Alcendor D., Wan X., Nicholas J., Browning P., Rady P., Tyring S., Orenstein J., Rabkin C., Su I., Powell K., Croxson M., Foreman K., Nickoloff B., Alkan S., Hayward G. High level variability in the ORF K1 membrane protein gene at the left end of KSHV genome defines four major virus subtypes and multiple variants or clades in different human populations. J. Virol. 73:1999;4156-4170.
15. Alagiozoglou L., Sitas F., Morris L. Phylogenetic analysis of HHV-8 in South Africa and identification of a novel subgroup. J. Gen. Virol. 81:2000;2029-2038.
16. Beyari M., Hodgson T., Cook R., Kondowe W., Molyneux E., Scully C., Teo C., Porter S. Multiple human herpesvirus 8 infection. J. Infect. Dis. 188:2003;678-689.
17. Miller G., Heston L., Grogan E., Gradonville L., Rigsby M., Sun R., Shedd D., Kushnariov V., Grossberg S., Chang Y. Selective switch between latency and lytic replication of KSV and EBV in dually infected body-cavity lymphoma cells. J. Virol. 71:1997;314-324.
18. Monini P., Colombini S., Sturzl M., Goletti D., Cafaro A., Sgadari C., Buttò S., Franco M., Leone P., Fais S., Leone P., Melucci-Vigo G., Chiozzini C., Carlini F., Ascherl G., Cornali E., Zietz C., Ramazzotti E., Ensoli F., Andreoni M., Pezzotti P., Rezza G., Yarchoan R., Gallo R.C., Ensoli B. Reactivation and persistence of HHV-8 infection in B-cells and monocytes by Th1 cytokines increased in Kaposi's sarcoma. Blood. 93:1999;4044-4058.
19. Pauk J., Huang M., Brodie S., Wald A., Koelle D., Schacker T., Celum C., Selke S., Corey L. Mucosal shedding of human herpesvirus 8 in men. New Engl. J. Med. 343:2000;1369-1377.
20. Koelle D., Huang M., Chandran B., Vieira J., Piepkorn M., Corey L. Frequent detection of KS-associated herpesvirus DNA in saliva of HIV-infected men: clinical and immunological correlates. J. Infect. Dis. 176:1997;94-102.
21. Rezza G., Capobanchi M., Serraino D., Peroni M., Piselli P., Calcaterra S., Pavia C., Zaniratti S., Ippolito G. HHV-8 shedding among HIV-infected women. J. Acquired Immune Defic. Syndr. 28:2001;103-104.
22. Blackbourn D., Levy J. HHV-8 in semen and prostate. AIDS. 11:1997;249-250.
23. Martin J., Ganem D., Osmond D., Page-Shafer K., Mcrae D., Kedes D. Sexual transmission and the natural history of HHV-8 infection. New Engl. J. Med. 338:1998;948-954.
24. Engels E., Sinclair M., Biggar R., Whitby D., Ebbesen P., Goedert J., Gastwirth J. Latent analysis of HHV-8 assay performance and infection prevalence in sub-Saharian Africa. Int. J. Cancer. 88:2000;1003-1008.
25. Belec R., Cancre N., Hallouin M., Morvan J., Si Mohamed A., Grenseguet G. High prevalence in central Africa of blood donors who are potentially infectious for HHV-8. Transfusion. 38:1998;771-775.
26. Andreoni M., El-Sawaf G., Rezza G., Ensoli B., Nicastri E., Ventura L., Ercoli L., Sarmati L., Rocchi G. High seroprevalence of antibodies to HHV-8 in Egyptian children: evidence for non sexual transmission. J. Natl. Cancer Inst. 91:1999;465-469.
27. Gessain A., Mauclere P., van Beveren M., Plancoulaine S., Ayouba A., Essame-Oyono J., Martin P., de The G. HHV-8 primary infection occurs during childhood in Cameroon, Central Africa. Int. J. Cancer. 81:1999;189-192.
28. Kedes D., Operskalski E., Bush M., Kohn R., Flood J., Ganem D. The seroepidemiology of HHV-8: distribution of infection in KS risk groups and evidence for sexual transmission. Nat. Med. 2:1996;918-924.
29. Cesarman E., Chang Y., Moore P., Said J., Knowles D. KSHV like DNA sequences in AIDS-related body cavity-based lymphomas. New Engl. J. Med. 332:1995;1186-1191.
30. Soulier J., Grollet L., Oksenhendler E., Cacoub P., Cazals-Hatem D., Babinet P., d'Agay M., Clauvel J., Raphael M., Degos L., Sigaux F. KSHV like DNA sequences in multicentric Castleman's disease. Blood. 86:1995;1276-1280.
31. Katano H., Sato Y., Kurata T., Mori S., Sata T. Expression and localization of HHV-8 encoded proteins in PEL, Kaposi's sarcoma and multicentric Castleman's disease. Virology. 269:2000;335-344.
32. Hengge U., Ruzicka T., Tyring S., Stutsche M., Roggendorf M., Schwartz R., Seeber S. Update on Kaposi's sarcoma and other HHV-8 associate diseases. Part 2: pathogenesis, Castleman's disease and pleural effusion lymphoma. Lancet Infect. Dis. 2:2002;344-352.
33. Coluzzi M., Manno D., Guzzinati S., Tognazzo S., Zambon P., Arca B., Costantini C., Ascoli V. The bloodsuckling arthropod bite as a possible cofactor in the transmission of HHV-8 infection and in the expression of KS disease. Parasitologia. 44:2002;123-129.
34. Rettig M., Ma H., Vescio R., Pold M., Schiller G., Belson D., Savage A., Nishikubo C., Wu C., Fraser J., Said J., Berenson J. KS associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patients. Science. 276:1997;1851-1854.
35. Tarte K., Chang Y., Klein B. KS associated herpesvirus and multiple myeloma: lack of criteria for causality. Blood. 93:1999;3159-3164.
36. Masood R., Zeng T., Tulpule A., Arora N., Chatlynne L., Handy M., Whitman J. KS associated herpesvirus infection and multiple myeloma. Science. 278:1997;1970-1973.
37. Tedeschi R., Kvarnung M., Knekt P., Schulz T., Szekely L., De Paoli P., Aromaa A., Teppo L., Dillner J. A prospective seroepidemiological study of HHV-8 infection and the risk of multiple myeloma. Br. J. Cancer. 84:2001;122-125.
38. Cool C., Rai P., Yeager M., Hernandez-Saavadra D., Serls A., Bull T., Geraci M., Brown K., Routes J., Tuder R., Voelkel N. Expression of HHV-8 in primary pulmonary hypertension. New Engl. J. Med. 349:2003;1113-1122.
39. Lebbè C., Blum L., Pellet C., Blanchard G., Verola O., Morel P., Danne O., Calvo F. Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposi's sarcoma. AIDS. 12:1998;F45-F49.
40. Sgadari C., Monini P., Barillari G., Ensoli B. Use of HIV protease inhibitors to block Kaposi's sarcoma and tumor growth. Lancet Oncol. 4:2003;537-547.
41. Medveczky M., Horvath E., Lund T., Medveczky P. In vitro antiviral drug sensitivity of KSHV. AIDS. 11:1997;1327-1332.
42. Tedeschi R., Dillner J., De Paoli P. Laboratory diagnosis of HHV-8 infection in humans. Eur. J. Clin. Microbiol. Infect. Dis. 21:2002;831-844.
43. Chandran B., Smith M., Koelle D., Corey L., Horvat R., Goldstein E. Reactivites of human sera with HHV-8 infected BCBL-1 cells and identification of HHV-8 specific proteins and the encoding c-DNAs. Virology. 243:1998;208-217.
44. Corchero J., Mac E., Spira T., Pellett P., Inoue N. Comparison of serologic assays for detection of antibodies against HHV-8. Clin. Diagn. Lab. Immunol. 8:2001;913-921.
45. Engels E., Whitby D., Goebel P., Stossel A., Waters D., Pintus A., Contu L., Biggar R., Goedert J. Identifying HHV-8 infection: performance characteristics of serological assays. J. Acquired Immune Defic. Syndr. 23:2000;346-354.
46. Andre S., Schatz O., Bogner J., Zeichard H., Stoffler-Melicke M., Jahn H., Ullrich R., Sonntag A., Kehm R., Haas J. Detection of antibodies against viral capsidic proteins of HHV-8 in AIDS-associated KS. J. Mol. Med. 75:1997;145-152.
47. Lang D., Hinderer W., Rothe M., Sonneborn H., Neipel F., Raab M., Rabenau H., Masquelier B., Fleury H. Comparison of IgG specific seroreactivity of different recombinant antigens of HHV-8. Virology. 260:1999;47-54.
48. Rabkin C., Schulz T., Whitby D., Lennette E., Magpantay L., Chatlynne L., Biggar R. Interassay correlation of HHV-8 serologic tests. J. Infect. Dis. 178:1998;304-309.
49. Pellett P., Wright D., Engels E., Ablashi D., Dollard S., Forghani B., Glynn S., Goedert J., Jenkins F., Lee T., Neipel F., Todd D., Whitby D., Nemo G., Bush M. Multicenter comparison of serologic assays and estimation of human herpesvirus 8 seroprevalence among US blood donors. Transfusion. 43:2003;1260-1268.
50. Schatz O., Monini P., Bugarini P., Neipel F., Schulz T., Andreoni M., Erb P., Eggers M., Haas J., Butto S., Lukwiya M., Bogner J., Yaguboglu S., Sheldon J., Sarmati L., Goebel F., Hintermaier R., Enders G., Regamey N., Wernly M., Sturzl M., Rezza G., Ensoli B. KSHV serology in Europe and Uganda: multicentre study with multiple and novel assays. J. Med. Virol. 65:2001;123-132.
51. Moore P., Chang Y. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection. New Engl. J. Med. 332:1995;1181-1185.
52. Ensoli B., Sgadari C., Barillari G., Sirianni M., Sturzl M., Monini P. Biology of Kaposi's sarcoma. Eur. J. Cancer. 37:2001;1251-1269.
53. Whitby D., Howard M., Tenant-Flowers M., Brink N., Copas A., Boshoff C., Hatzioannou T., Suggett F., Aldam M., Denton A., Miller R., Weller I., Weiss R., Tedder R., Schulz T. Detection of KSHV in peripheral blood of HIV-infected individuals and progression to KS. Lancet. 346:1995;799-802.
54. Pellett P., Spira T., Bagasra O., Boshoff C., Corey L., de Lellis L., Huang M., Lin J., Matthews S., Monini P., Rimessi P., Sosa C., Wood C., Steward J. Multicenter comparison of PCR assays for detection of HHV-8 DNA in semen. J. Clin. Microbiol. 37:1999;1298-1301.
55. Tedeschi R., Enbom M., Bidoli E., Linde A., De Paoli P., Dillner J. Viral load of HHV-8 in peripheral blood of HIV-infected patients with KS. J. Clin. Microbiol. 39:2001;4269-4273.
56. Lallemand F., Desire N., Rozembaum W., Nicholas J., Marechal V. Quantitative analysis of HHV-8 viral load using a real-time PCR assay. J. Clin. Microbiol. 38:2000;1404-1408.
57. Dittmer D. Transcription profile of KSHV in primary KS lesions as determined by real-time PCR arrays. Cancer Res. 63:2003;2010-2015.
58. Fakhari F., Dittmer D. Charting latency transcripts in KSHV by whole genome real-time quantitative PCR. J. Virol. 76:2002;6213-6223.
59. Merat R., Amara A., Lebbe C., de The H., Morel P., Saib A. HIV-1 infection of PEL cell line triggers KSHV reactivation. Int. J. Cancer. 97:2002;791-795.
60. P. Trvedi, K. Takazawa, C. Zompetta, L. Cuomo, E. Anastasiadou, A. Carbone, S. Uccini, F. Belardelli, K. Takada, L. Frati, A. Faggioni, Infection of HHV-8 positive PEL cells with a recombinant EBV lead to restricted EBV latency, altered phenotype and increased tumorigenicity without affecting TCL1 expression, Blood 103 (2004) 313-316.
61. Regamey R., Yamm M., Wernli M., Thiel G., Cathomas G., Erb P. Transmission of HHV-8 infection from renal transplant donors to recipients. New Engl. J. Med. 339:1998;1358-1363.
62. Farge D., Lebbè C., Marjanovic Z., Tuppin P., Mouquet C., Peraldi M., Lang P., Hiesse C., Antoine C., Legendre C., Bedrossian J., Gagnadoux M.F., Lorat C., Pellet C., Sheldon J., Golmard J., Agbalika F., Schulz T. HHV-8 and other risk factors for Kaposi's sarcoma in kidney transplant recipients. Transplantation. 67:1999;1236-1242.
63. Pellet C., Chevret S., Frances C., Euvrard S., Hurault M., Legendre C., Dalac S., Farge D., Antoine C., Hiesse C., Peraldi M., Lang P., Samuel D., Calmus Y., Agbalika F., Morel P., Calvo F., Lebbè C. Prognostic value of quantitative KSHV load in posttransplantation Kaposi's sarcoma. J. Infect. Dis. 186:2002;110-113.
64. Barozzi P., Luppi M., Facchetti F., Meucci C., Alu M., Sarid R., Rasini V., Ravazzini L., Rossi E., Festa S., Crescenzi B., Wolf D., Schulz T., Torelli G. Post-transplant KS originates from the seeding of donor-derived progenitors. Nat. Med. 9:2003;554-561.